Dr. Reddy’s Laboratories Ltd (DRREDDY):医療機器:M&Aディール及び事業提携情報

【英語タイトル】Dr. Reddy's Laboratories Ltd (DRREDDY) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C7163)・商品コード:DATA904C7163
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:59
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Dr. Reddy’s Laboratories Ltd (Dr. Reddy’s) is a pharmaceutical company which manufactures and markets generic formulations, active pharmaceutical ingredients, biosimilars and proprietary products. The company’s generic products are used for the treatment of conditions such as gastrointestinal disorders, oncology, cardiovascular diseases, pain management, Central Nervous System, cancer, pain, infectious diseases and pediatrics. The company provides more than 150 products. The company also develops generic biosimilar products and has four products in the market. The company also discovers, develops, manufactures and markets New Chemical Entities (NCEs) focusing on bacterial infections, metabolic disorders, pain and inflammation. The company markets products in over 75 countries in the US, Europe, Latin America and Asia. Dr. Reddy’s is headquartered in Hyderabad, Telangana, India.

Dr. Reddy’s Laboratories Ltd (DRREDDY) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Dr. Reddy’s Laboratories Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Dr. Reddy’s Laboratories Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Dr. Reddy’s Laboratories Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Dr. Reddy’s Laboratories Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Dr. Reddy’s Laboratories Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Dr. Reddy’s Laboratories Ltd, Medical Equipment, Deal Details 11
Private Equity 11
Cipla, Zydus Cadilla, Dr. Reddy’s Labs and Baring Asia May Acquire Bharat Serums and Vaccines 11
Partnerships 13
Dr. Reddy’s Labs and Integra LifeSciences Holdings Enter into Distribution Agreement 13
CytoSorbents Enters into Agreement with Dr. Reddy’s Labs 14
Equity Offering 15
Octoplus Completes First Tranche Of Private Placement Of Common Stock For US$1.6 Million 15
Acquisition 16
Dr Reddy’s Labs Acquires OctoPlus 16
Dr. Reddy’s Laboratories Ltd – Key Competitors 18
Dr. Reddy’s Laboratories Ltd – Key Employees 19
Dr. Reddy’s Laboratories Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 23
Recent Developments 24
Financial Announcements 24
Jul 26, 2018: Dr. Reddy’s Q1 FY19 financial results 24
May 22, 2018: Dr. Reddy’s Q4 and FY18 Financial Results 26
Jan 25, 2018: Dr. Reddy’s Q3 and 9M FY18 Financial Results 28
Oct 31, 2017: Dr. Reddy’s Q2 and H1 FY18 Financial Results 30
Jul 27, 2017: Dr. Reddy’s Q1 FY18 Financial Results 31
May 12, 2017: Dr. Reddy’s Q4 and FY17 Financial Results 32
Feb 04, 2017: Dr. Reddy’s Q3 and 9M FY17 Financial Results 34
Corporate Communications 36
Jun 14, 2018: Dr. Reddy’s Announces Resignation of Hans Peter Hasler As Independent Director 36
Mar 29, 2018: Dr. Reddy’s Laboratories announces Senior Leadership Changes 37
Oct 30, 2017: Dr Reddys Laboratories appoints Prasad R Menon as an Additional Director 38
Legal and Regulatory 39
Aug 23, 2018: Dr. Reddy’s Laboratories: Update on audit of API Srikakulam Plant, Andhra Pradesh 39
Jun 28, 2018: Dr. Reddy’s Laboratories: Update on Audit of its API Hyderabad Plant 3 and API Hyderabad Plant 1 40
Jun 02, 2018: Dr. Reddy’s Laboratories Provides Update on US FDA Inspection of its API Srikakulam Plant 41
Apr 24, 2018: Dr. Reddy’s Laboratories Provides Update on US FDA Inspection of its API Plant in Mirfield, UK 42
Feb 25, 2018: Dr. Reddy’s Laboratories Provides Update on USFDA Audit of its API Manufacturing Plant at Srikakulam, India 43
Feb 19, 2018: Dr Reddy’s Laboratories: Update on US Lawsuit 44
Jan 24, 2018: Dr. Reddy’s Laboratories: Intimation regard to Communication from Betapharm Arzneimittel, Germany from the Regulatory Authority of Germany 45
Dec 01, 2017: Dr. Reddy’s Laboratories: Intimation regard to the US FDA audit 46
Sep 21, 2017: Dr. Reddy’s Laboratories: Intimation about audit of Srikakulam Plant Unit II, Andhra Pradesh, by the US FDA 47
Sep 15, 2017: Dr. Reddy’s Laboratories: Intimation about audit of API Mirfield Plant, United Kingdom, by the US FDA 48
Sep 08, 2017: Dr. Reddy’s Laboratories: Regulatory Authority of Germany concludes audit of Formulations manufacturing facility in Vishakapatnam, India 49
Sep 08, 2017: Dr. Reddy’s Laboratories Announces Intimation on audit 50
Jul 21, 2017: Dr. Reddy’s Laboratories: Update On US FDA Audit at API Cuernavaca Plant 51
Jun 16, 2017: Dr. Reddy’s Laboratories: Update on USFDA Audit 52
Jun 14, 2017: Dr. Reddy’s Provides Update on API manufacturing plant at Miryalaguda 53
May 25, 2017: Dr. Reddy’s Laboratories Provides Update on Srikakulum Plant 54
Apr 14, 2017: Dr. Reddy’s Provides Update on USFDA Audit 55
Apr 03, 2017: Dr. Reddy’s Laboratories Provides Update on USFDA Inspection at Srikakulam plant 56
Feb 21, 2017: Dr. Reddy’s Laboratories Announces US FDA Inspection on Miryalaguda Facility 57
Other Significant Developments 58
Feb 08, 2017: Dr. Reddy’s Expands Commercial Operations in Europe 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59

List of Tables
Dr. Reddy's Laboratories Ltd, Medical Equipment, Key Facts, 2018 2
Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Dr. Reddy's Laboratories Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Dr. Reddy's Laboratories Ltd, Deals By Market, 2012 to YTD 2018 9
Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Cipla, Zydus Cadilla, Dr. Reddy’s Labs and Baring Asia May Acquire Bharat Serums and Vaccines 11
Dr. Reddy’s Labs and Integra LifeSciences Holdings Enter into Distribution Agreement 13
CytoSorbents Enters into Agreement with Dr. Reddy's Labs 14
Octoplus Completes First Tranche Of Private Placement Of Common Stock For US$1.6 Million 15
Dr Reddy's Labs Acquires OctoPlus 16
Dr. Reddy's Laboratories Ltd, Key Competitors 18
Dr. Reddy's Laboratories Ltd, Key Employees 19
Dr. Reddy's Laboratories Ltd, Subsidiaries 20
Dr. Reddy's Laboratories Ltd, Joint Venture 23

List of Figures
Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★調査レポート[Dr. Reddy’s Laboratories Ltd (DRREDDY):医療機器:M&Aディール及び事業提携情報] (コード:DATA904C7163)販売に関する免責事項を必ずご確認ください。
★調査レポート[Dr. Reddy’s Laboratories Ltd (DRREDDY):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆